OR WAIT null SECS
March 02, 2016
Siegfried Schmitt, principal consultant, PAREXEL, discusses how the regulatory requirements for CGMPs is the different phases of drug development and manufacture.
Thought leaders tackle drug shortages and manufacturing innovations.
February 02, 2016
Suppliers must develop new technologies to drive the bio/pharma innovation engine.
January 02, 2016
Infrastructure and payer decisions will determine drug choices in emerging and developed regions.
December 02, 2015
Employers have work to do to improve job satisfaction and retain qualified workers.
November 02, 2015
Siegfried Schmitt, principal consultant, PAREXEL, discusses how to ensure archive records can be retrieved.
The CPhI Pharma Awards celebrate innovations in the pharma industry.
October 13, 2015
A CPhI report suggests that the pharma industry should be careful not to outsource to lower labor-cost countries rather than investing in manufacturing technology and innovation.
A CPhI report predicts how two potential mega free-trade deals, one among Pacific-Rim countries and the other between the US and EU, could affect pharmaceutical companies.
October 02, 2015
In the development of biopharmaceuticals and pharmaceuticals, the line is blurring.